BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6264545)

  • 1. The effect of iron on the biodistribution of bone scanning agents in humans.
    Choy D; Murray IP; Hoschl R
    Radiology; 1981 Jul; 140(1):197-202. PubMed ID: 6264545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of age on the quality of bone scans using technetium-99m pyrophosphate.
    Wilson MA
    Radiology; 1981 Jun; 139(3):703-5. PubMed ID: 6262860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metastatic calcifications as demonstrated by technetium-99m-pyrophosphate bone scanning. Case reports].
    Louw NW; Klopper JF; van Heerden PD
    S Afr Med J; 1982 Oct; 62(17):617-20. PubMed ID: 6289479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Skeletal scintigraphy using pyrophosphate 99mTc].
    Zubovskiĭ GA; Turaev RN; Khripta FP; Aslanov IaI
    Med Radiol (Mosk); 1978 Feb; 23(2):32-7. PubMed ID: 204849
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
    Hodson EM; Howman-Giles RB; Evans RA; Bautovich G; Hills EE; Sherbon K; Bach BD; Horvath JS; Tiller DJ
    Clin Nephrol; 1981 Jul; 16(1):24-8. PubMed ID: 6268343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft tissue uptake of bone seeking radionuclide in amyloidosis.
    Yood RA; Skinner M; Cohen AS; Lee VW
    J Rheumatol; 1981; 8(5):760-6. PubMed ID: 6273552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scintigraphy in focal lesions of the bones].
    Vlakhov N; Mirchev V; Popov B
    Med Radiol (Mosk); 1987 Feb; 32(2):58-9. PubMed ID: 3027494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abnormal accumulation of 99mTc-pyrophosphate in a patient with amyloidosis: case report].
    Sakakibara N; Nakayama C; Mihara F; Nakata H; Yamasaki Y; Oda S
    Rinsho Hoshasen; 1986 Jan; 31(1):135-8. PubMed ID: 3009927
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-scintigraphic studies of bone disease (renal osteodystrophy) in patients on chronic hemodialysis (preliminary report)].
    Ionova D; Garcheva M; Simeonova A; Kiriakov Z
    Vutr Boles; 1988; 27(2):107-12. PubMed ID: 2842966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the accuracy of bone scintigraphy in breast tumors].
    Pupi A; Castagnoli A; Ciatto S; Meldolesi U
    Radiol Med; 1980 Nov; 66(11):842-4. PubMed ID: 6261307
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone scintigraphy with 99mTc-pyrophosphate in the diagnosis of the degree of the spread of the tumor process in the head and neck area].
    Prikhod'ko AG
    Med Radiol (Mosk); 1982 Jan; 27(1):58-67. PubMed ID: 6276643
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 14. The technetium phosphate bone scan in the diagnosis of osteomyelitis in childhood.
    Howie DW; Savage JP; Wilson TG; Paterson D
    J Bone Joint Surg Am; 1983 Apr; 65(4):431-7. PubMed ID: 6300132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of 99mTc pyrophosphate bone scintigraphy for vitamin D trials in uraemia.
    Vanherweghem JL; Dhaene M; Tielemans C; Dratwa M; Verbanck P; Bergmann P; Schoutens A; Fuss M
    Proc Eur Dial Transplant Assoc; 1981; 18():648-51. PubMed ID: 6276883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of liposarcoma; the concentration of Tc-PYP and Ga-citrate was the useful indicator of the effect of transarterial embolization].
    Kobayashi H; Itoh T; Kato T; Fujita Y; Murata R; Tanabe M; Konishi J
    Rinsho Hoshasen; 1990 Sep; 35(9):1101-4. PubMed ID: 2172604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrophosphate retention by previously irradiated renal tissue.
    Lutrin CL; Goris ML
    Radiology; 1979 Oct; 133(1):207-9. PubMed ID: 224416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of 99mTc-pyrophosphate injection with gentisic acid.
    Ballinger J; Der M; Bowen B
    Eur J Nucl Med; 1981 Apr; 6(4):153-4. PubMed ID: 6260499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.